Your browser doesn't support javascript.
loading
Antifungal susceptibility testing results of New Zealand yeast isolates, 2001-2015: Impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species.
Morris, Arthur J; Rogers, Karen; McKinney, Wendy P; Roberts, Sally A; Freeman, Joshua T.
Affiliation
  • Morris AJ; New Zealand Mycology Reference Laboratory, LabPLUS, Auckland City Hospital, Auckland, New Zealand. Electronic address: arthurm@adhb.govt.nz.
  • Rogers K; New Zealand Mycology Reference Laboratory, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
  • McKinney WP; New Zealand Mycology Reference Laboratory, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
  • Roberts SA; New Zealand Mycology Reference Laboratory, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
  • Freeman JT; New Zealand Mycology Reference Laboratory, LabPLUS, Auckland City Hospital, Auckland, New Zealand.
J Glob Antimicrob Resist ; 14: 72-77, 2018 09.
Article in En | MEDLINE | ID: mdl-29486358
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pichia / Candida / Microbial Sensitivity Tests / Antifungal Agents Limits: Humans Country/Region as subject: Oceania Language: En Journal: J Glob Antimicrob Resist Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pichia / Candida / Microbial Sensitivity Tests / Antifungal Agents Limits: Humans Country/Region as subject: Oceania Language: En Journal: J Glob Antimicrob Resist Year: 2018 Document type: Article Country of publication: